Supp Fig 7 from ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC

作者：Natalie I. Vokes, Ana Galán‐Cobo, Margarita Fernandez-Chas, David Molkentine, Santiago Treviño, Vitaly Druker, Yu Qian, Sonia Patel, Stephanie Schmidt, Lingzhi Hong, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, J. Jack Lee, Marcelo V. Negrão, Don L. Gibbons, Ara A. Vaporciyan, Xiuning Le, Jia Wu, Jianjun Zhang, Una Rigney, Sonia Iyer, Emma Dean, John V. Heymach · 年份：2025 · DOI：10.1158/1078-0432.30902840 · 研究领域：Cancer Immunotherapy and Biomarkers、PARP inhibition in cancer therapy、Lung Cancer Treatments and Mutations

<p>Supp Figure 7. Immune checkpoint inhibitor (ICI) monotherapy vs with chemotherapy in ATM-mutated patients.</p>